Compile Data Set for Download or QSAR
Report error Found 4 Enz. Inhib. hit(s) with all data for entry = 13509
TargetE3 ubiquitin-protein ligase CBL(Homo sapiens)
Hotspot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 800723BDBM800723(US20260085070, Compound 1)
Affinity DataIC50: 1.00E+3nMAssay Description:Compounds are 3-told serially diluted in DMSO in a 384-well polypropylene plate (e.g., #P-05525-BC; Labcyte) to generate a source plate with 10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase CBL(Homo sapiens)
Hotspot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 800724BDBM800724(US20260085070, Compound 2)
Affinity DataIC50: 2.00E+4nMAssay Description:Compounds are 3-told serially diluted in DMSO in a 384-well polypropylene plate (e.g., #P-05525-BC; Labcyte) to generate a source plate with 10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase CBL(Homo sapiens)
Hotspot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 800725BDBM800725(US20260085070, Compound 3)
Affinity DataIC50: 2.00E+4nMAssay Description:Compounds are 3-told serially diluted in DMSO in a 384-well polypropylene plate (e.g., #P-05525-BC; Labcyte) to generate a source plate with 10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent

TargetE3 ubiquitin-protein ligase CBL(Homo sapiens)
Hotspot Therapeutics

US Patent
LigandChemical structure of BindingDB Monomer ID 800726BDBM800726(US20260085070, Compound 4)
Affinity DataIC50: 2.00E+4nMAssay Description:Compounds are 3-told serially diluted in DMSO in a 384-well polypropylene plate (e.g., #P-05525-BC; Labcyte) to generate a source plate with 10 conce...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
8/5/2026
Entry Details
US Patent